AMENDMENT TO WARRANT TO PURCHASE COMMON STOCKWarrant to Purchase Common Stock • February 12th, 2020 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 12th, 2020 Company Industry JurisdictionThis Amendment (this “Amendment”) to Warrant to Purchase Common Stock (the “Warrant”), is made and entered into effective as of the Expiration Date (as defined in this Amendment), by and between Innovate Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and the undersigned (the “Holder”). Capitalized terms used but not otherwise defined herein shall have the same meanings as set forth in the Warrant.